Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR

Autor: de la Fouchardière, Christelle, Godbert, Yann, Dalban, Cécile, Illouz, Frédéric, Wassermann, Johanna, Do Cao, Christine, Bardet, Stéphane, Zerdoud, Slimane, Chougnet, Cécile N., Zalzali, Mohamed, Benisvy, Danielle, Niccoli, Patricia, Digue, Laurence, Lamartina, Livia, Schwartz, Paul, Borson Chazot, Françoise, Gautier, Julien, Pérol, David, Leboulleux, Sophie
Zdroj: In European Journal of Cancer November 2021 157:153-164
Databáze: ScienceDirect
Externí odkaz: